Log in to save to my catalogue

Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production...

Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea08eade784649d4864f5e4a0a35dbf8

Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line

About this item

Full title

Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2023-01, Vol.28 (3), p.1261

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Non-alcoholic fatty liver disease (NAFLD) is an emerging chronic liver disease worldwide. Curcumin and andrographolide are famous for improving hepatic functions, being able to reverse oxidative stress and release pro-inflammatory cytokines, and they are implicated in hepatic stellate cell activation and in liver fibrosis development. Thus, we test...

Alternative Titles

Full title

Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ea08eade784649d4864f5e4a0a35dbf8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea08eade784649d4864f5e4a0a35dbf8

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules28031261

How to access this item